1.
Wolfenstein-Todel C, Mosesson MW. Human plasma fibrinogen heterogeneity: evidence
for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').
Proc Natl Acad Sci U S A. 1980;77:5069-73.
2.
Mosesson MW, Finlayson JS. Subfractions of Human Fibrinogen; Preparation and Analysis.
J Lab Clin Med. 1963;62:663-74.
3.
Chung DW, Davie EW. Gamma and gamma' chains of human fibrinogen are produced by alternative
mRNA processing. Biochemistry. 1984;23:4232-6.
4.
Fornace AJ Jr, Cummings DE, Comeau CM, Kant JA, Crabtree GR. Structure of the human
gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces
gamma A and gamma B forms of gamma-fibrinogen. J Biol Chem. 1984;259:12826-30.
5.
Meh DA, Siebenlist KR, Mosesson MW. Identification and characterization of the thrombin
binding sites on fibrin. J Biol Chem. 1996;271:23121-5.
6.
Kloczewiak M, Timmons S, Hawiger J. Localization of a site interacting with human
platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. Biochem
Biophys Res Commun. 1982;107:181-7.
7.
Lancellotti S, Rutella S, De Filippis V, Pozzi N, Rocca B, De Cristofaro R. Fibrinogen-elongated
gamma chain inhibits thrombin-induced platelet response, hindering the interaction
with different receptors. J Biol Chem. 2008;283:30193-204.
8.
Macrae FL, Domingues MM, Casini A, Ariëns RA.The (Patho)physiology of Fibrinogen gamma'.
Semin Thromb Hemost. 2016;42:344-55.
9.
Mosesson MW. Update on antithrombin I (fibrin). Thromb Haemost. 2007;98:105-8.
10.
Fredenburgh JC, Stafford AR, Leslie BA, Weitz JI. Bivalent binding to gammaA/gamma'-fibrin
engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin
complex. J Biol Chem. 2008;283:2470-7.
11.
Uitte de Willige S, Standeven KF, Philippou H, Ariëns RA. The pleiotropic role of
the fibrinogen gamma' chain in hemostasis. Blood. 2009;114:3994-4001.
12.
Moaddel M, Farrell DH, Daugherty MA, Fried MG. Interactions of human fibrinogens with
factor XIII: roles of calcium and the gamma' peptide. Biochemistry. 2000;39:6698-705.
13.
Gersh KC, Lord ST. An investigation of factor XIII binding torecombinant gamma'/gamma'
and gamma/gamma' fibrinogen (abstract). Blood. 2006;108:485a.
14.
Siebenlist KR, Meh DA, Mosesson MW. Protransglutaminase (factor XIII) mediated crosslinking
of fibrinogen and fibrin. Thromb Haemost. 2001;86:1221-8.
15.
Lovely RS, Boshkov LK, Marzec UM, Hanson SR, Farrell DH. Fibrinogen gamma' chain carboxy
terminal peptide selectively inhibits the intrinsic coagulation pathway. Br J Haematol.
2007;139:494-503.
16.
Omarova F, Uitte De Willige S, Ariëns RA, Rosing J, Bertina RM, Castoldi E. Inhibition
of thrombin-mediated factor V activation contributes to the anticoagulant activity
of fibrinogen gamma'. J Thromb Haemost. 2013;11:1669-78.
17.
Omarova F, Uitte de Willige S, Simioni P, Ariëns RA, Bertina RM, Rosing J, et al.
Fibrinogen gamma' increases the sensitivity to activated protein C in normal and factor
V Leiden plasma. Blood. 2014;124:1531-8.
18.
Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated
with electron microscope and turbidity observations: clot structure and assembly are
kinetically controlled. Biophys J. 1992;63:111-28.
19.
Lord ST. Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr Opin Hematol.
2007;14:236-41.
20.
Cooper AV, Standeven KF, Ariëns RA. Fibrinogen gamma-chain splice variant gamma' alters
fibrin formation and structure. Blood. 2003;102:535-40.
21.
Siebenlist KR, Mosesson MW, Hernandez I, Bush LA, Di Cera E, Shainoff JR, et al. Studies
on the basis for the properties of fibrin produced from fibrinogen-containing gamma'
chains. Blood. 2005;106:2730-6.
22.
Allan P, Uitte de Willige S, Abou-Saleh RH, Connell SD, Ariëns RA. Evidence that fibrinogen
gamma' directly interferes with protofibril growth: implications for fibrin structure
and clot stiffness. J Thromb Haemost. 2012;10:1072-80.
23.
Falls LA, Farrell DH. Resistance of gammaA/gamma' fibrin clots to fibrinolysis. J
Biol Chem. 1997;272:14251-6.
24.
Rein-Smith CM, Anderson NW, Farrell DH. Differential regulation of fibrinogen gamma
chain splice isoforms by interleukin-6. Thromb Res. 2013;131:89-93.
25.
Ribes JA, Francis CW, Wagner DD. Fibrin induces release of von Willebrand factor from
endothelial cells. J Clin Invest. 1987;79:117-23.
26.
Schleef RR, Birdwell CR. Biochemical changes in endothelial cell monolayers induced
by fibrin deposition in vitro. Arteriosclerosis. 1984;4:14-20.
27.
Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography.
Science. 1970;170:1095-6.
28.
Jakobsen E, Kierulf P. A modified beta-alanine precipitation procedure to prepare
fibrinogen free of antithrombin-III and plasminogen. Thromb Res. 1973;3:145–149.
29.
Castillo O, Rojas H, Domínguez Z, Angles-Cano E, Marchi R. Endothelial fibrinolytic
response onto an evolving matrix of fibrin. BMC Hematol. 2016;16:9.
30.
Cantero M, Cardinali B, Marchi R. Purification of fibrinogen gamma A/gamma prime ( γA/ γ’) by fast protein liquid chromatography. Rev Colomb Quim. 2018;47:24-30.
31.
Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces
human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-20.
32.
Ariëns RA. Fibrin(ogen) and thrombotic disease. J Thromb Haemost. 2013;11(Suppl 1):294-305.
33.
Kim PY, Vu TT, Leslie BA, Stafford AR, Fredenburgh JC, Weitz JI.Reduced plasminogen
binding and delayed activation render gamma'-fibrin more resistant to lysis than gammaA-fibrin.
J Biol Chem. 2014;289:27494-503.
34.
Collet JP, Nagaswami C, Farrell DH, Montalescot G, Weisel JW. Influence of gamma'
fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler
Thromb Vasc Biol. 2004;24:382-6.
35.
Gersh KC, Nagaswami C, Weisel JW, Lord ST. The presence of gamma' chain impairs fibrin
polymerization. Thromb Res 2009;124:356-63.
36.
Mandl-Weber S, Haslinger B, Sitter T. Thrombin upregulates production of plasminogen
activator inhibitor type 1 in human peritoneal mesothelial cells. Perit Dial Int.
1999;19:319-24.
37.
Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H, et al. Activation
of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism
that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood.
2007;110:2432-9.
38.
Lacroix R, Plawinski L, Robert S, Doeuvre L, Sabatier F, Martinez S, et al. Leukocyte-
and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica.
2012;97:1864-72.
39.
Doeuvre L, Plawinski L, Goux D, Vivien D, Anglés-Cano E. Plasmin on adherent cells:
from microvesiculation to apoptosis. Biochemical J. 2010;432:365-73.
40.
Lovely RS, Moaddel M, Farrell DH. Fibrinogen gamma' chain binds thrombin exosite II.
J Thromb Haemost. 2003;1:124-31.
41.
Domingues MM, Macrae FL, Duval C, McPherson HR, Bridge KI, Ajjan RA, et al. Thrombin
and fibrinogen gamma' impact clot structure by marked effects on intrafibrillar structure
and protofibril packing. Blood. 2016;127:487-95.